“Our team has demonstrated that the existing and growing fleet of cyclotrons in Canada—which already make isotopes for PET imaging—can be successfully used to make high-quality technetium-99m to diversify the supply of this isotope,” said TRIUMF team member François Bénard, an imaging researcher at the University of British Columbia and senior scientist at Vancouver’s BC Cancer Agency.
https://cen.acs.org/articles/90/i10/Making-Technetium-99m.ht...

“Our philosophy all along has been to enable our existing Canadian infrastructure,” said Paul Schaffer, associate lab director of TRIUMF’s Life Science Division and head of the project. “Canada has one of the world’s most advanced fleet of cyclotrons in hospitals and research institutions. This provides very significant production capacity.”
https://www.google.ru/url?sa=t&rct=j&q=&esrc=s&source=web&cd...